Indiabulls Housing Finance sells 10% stake in OakNorth Bank for Rs 770 cr to GIC Singapore.

HOEC is the first out of the 31 Cos that signed contracts for fields won in the March auction, to have submitted a field development plan.

Dr Reddy’s Laboratories launches anti-cancer drug in US market.

GAIL: Revenue +4.5% At 12,409.7 Cr. EBITDA +35%.Margin At 16.7% vs 12.9%. Net Profit +42% @ 1,309.6 Cr.

Shreyas Shipping & Logistics:Revenue up 34% at 123.5cr. EBITDA at 26.8cr vs 7.4cr. Margins at 21.7% vs 8%. PAT at 19.7cr vs 2.4cr.

Waterbase: Revenue UP 21% at 96.6cr. EBITDA up 193% at 15.5cr. Margins at 15.5% vs 6.4%. PAT up 276% at 9.4cr.

MOIL: Revenue up 46% at 286.7cr. EBITDA at 116cr vs 18.7cr. Margins at 40.6% vs 9.5% PAT at 92.6cr vs 41.4cr.

Stocks to watch:

New User?Register Now

Research Disclaimer

Proficient Equities Pvt. Ltd. is engaged in services of retail broking and shares research data and reports periodically with clients, investors, stakeholders and general public in compliance with SEBI Act, 1992, SEBI (Research Analysts) Regulations, 2014 and/or any other applicable directives, instructions or guidelines issued by the Regulators from time to time.

Proficient Equities Pvt. Ltd. (hereinafter referred to as “Proficient”) is a registered Member of NSE Limited, BSE Limited, MSEI Limited and its associate is member of MCX and NCDEX stock Exchange. It is also registered as a Depository Participant with CDSL.

Our research report is for your general information only and reproducing, re-circulating, publishing it in any media,website, in partial form or as a whole, without the express consent of Proficient Equities Pvt. Ltd. is prohibited. The
report is meant solely for use by the original recipient to whom it is sent. It does not take into account the particular investment objectives, financial situations, or needs of individual clients. The recommendations, if any, made herein are expression of views and/or opinions and should not be deemed or construed to be neither advice/offer for the purpose of purchase or sale of any securities mentioned herein. Investor should rely on information/data arising out of their own investigations. Investors are advised to seek independent professional advice and arrive at an informed trading/investment decision before executing any trades or making any investments.

Proficient or its associates including its relatives/analyst do not hold any financial interest/beneficial ownership of more than 1% in the company covered by Analyst. Proficient or its associates/ relatives neither has been debarred/suspended by SEBI or any other regulatory authority/exchange for accessing/ dealing in securities Market nor have any material conflict of interest. Proficient or its associates/ analyst have neither received any compensation from the company covered by Analyst during the past twelve months nor any subject company have been a client of Proficient during the past twelve months. Proficient or its associates has not received any compensation or other benefits from the company covered by analyst or third party in connection with the research report. The Analyst has not served as an officer, director or employee of company covered by Analyst and Proficient has not been engaged in market making activity of the company covered by Analyst.

The views expressed are based solely on information available publicly available/internal data/ other reliable sources believed to be true.Proficient does not represent/ provide any warranty express or implied to the accuracy, contents or views expressed herein and investors are advised to independently evaluate the market conditions/risks involved before making any investment decision.

SEBI Research Analyst Reg. No. INH 300002498
Proficient Equities Pvt. Ltd.